Skip to main content

What the FDA labels say about taking them together

Cobicistat and timolol

Cobicistat's FDA label of February 10, 2026 names timolol in its drug interactions section; the timolol labels PlainMeds reads (4) do not name cobicistat. The cobicistat label: “Clinical monitoring is recommended for coadministration with beta-blockers that are metabolized by CYP2D6.”

Check it at the source: the cobicistat FDA label on DailyMed (effective February 10, 2026, Gilead Sciences, Inc.); the timolol FDA label on DailyMed (effective June 27, 2025, Thea Pharma Inc.).

What does the cobicistat label say about timolol?

Cobicistat label, drug interactions

Concomitant Drug Class/Drug Name: Beta-Blockers: e.g., metoprolol carvedilol timolol; Potential Effect ↑ = Increase, ↓ = Decrease, ↔ = No change: ↑ beta-blockers; Clinical Comment: Clinical monitoring is recommended for coadministration with beta-blockers that are metabolized by CYP2D6.

Source: FDA drug label (Tybost), Gilead Sciences, Inc., effective February 10, 2026 (SPL set 3784c35c-e87f-410c-900b-8fd6313c6010), via openFDA; the full label on DailyMed

What does the timolol label say about cobicistat?

Timolol's label (effective June 27, 2025) and its 3 other brand-application labels do not name cobicistat in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (BETIMOL), Thea Pharma Inc., effective June 27, 2025 (SPL set 3ae775f4-340c-4bf4-aa49-8a31daba0f8b), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

0Cobicistat generic labelers
22Timolol generic labelers
CobicistatTimolol
Labeled forHIVGlaucoma, High blood pressure, Migraine
Boxed warningNoNo
Pharmacy cost (NADAC)n/a$0.774 per mL 0.5% eye drops
Shortage nowA presentation being discontinuedNo current entry

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?